Sarah L. George

2.8k total citations
32 papers, 1.8k citations indexed

About

Sarah L. George is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Sarah L. George has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 13 papers in Infectious Diseases and 12 papers in Hepatology. Recurrent topics in Sarah L. George's work include Hepatitis C virus research (12 papers), HIV Research and Treatment (7 papers) and Hepatitis B Virus Studies (7 papers). Sarah L. George is often cited by papers focused on Hepatitis C virus research (12 papers), HIV Research and Treatment (7 papers) and Hepatitis B Virus Studies (7 papers). Sarah L. George collaborates with scholars based in United States, India and Spain. Sarah L. George's co-authors include Jack T. Stapleton, Jinhua Xiang, Donna Klinzman, Sabina Wünschmann, Banumathi Ramakrishna, Balamurugan Ramadass, Elizabeth M. Brunt, Adrian M. Di Bisceglie, Bruce R. Bacon and Ethendhar Rajendiran and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Sarah L. George

32 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah L. George United States 20 881 760 481 394 364 32 1.8k
Mohamed Tarek M. Shata United States 28 894 1.0× 1.2k 1.6× 595 1.2× 258 0.7× 268 0.7× 77 2.3k
Matthias Stoll Germany 29 1.1k 1.3× 551 0.7× 1.3k 2.8× 428 1.1× 930 2.6× 104 3.2k
J Giron Spain 21 768 0.9× 283 0.4× 512 1.1× 120 0.3× 273 0.8× 61 1.7k
Manfred Dietrich Germany 17 770 0.9× 571 0.8× 561 1.2× 98 0.2× 354 1.0× 42 2.1k
Caterina Uberti‐Foppa Italy 22 1.0k 1.2× 433 0.6× 632 1.3× 70 0.2× 328 0.9× 109 1.7k
Élisabeth Dussaix France 30 1.8k 2.1× 1.3k 1.7× 884 1.8× 141 0.4× 400 1.1× 90 3.0k
Pompeyo Viciana Spain 31 1.1k 1.2× 446 0.6× 1.7k 3.5× 226 0.6× 1.2k 3.3× 131 2.9k
Daniel P. Webster United Kingdom 14 493 0.6× 406 0.5× 330 0.7× 253 0.6× 185 0.5× 23 1.3k
George F. Grady United States 23 781 0.9× 325 0.4× 630 1.3× 465 1.2× 225 0.6× 37 2.2k
William P. Bradley United States 22 459 0.5× 244 0.3× 400 0.8× 241 0.6× 167 0.5× 47 1.3k

Countries citing papers authored by Sarah L. George

Since Specialization
Citations

This map shows the geographic impact of Sarah L. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah L. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah L. George more than expected).

Fields of papers citing papers by Sarah L. George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah L. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah L. George. The network helps show where Sarah L. George may publish in the future.

Co-authorship network of co-authors of Sarah L. George

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah L. George. A scholar is included among the top collaborators of Sarah L. George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah L. George. Sarah L. George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Scott, June Ann D’Angelo, R. Mark L. Buller, et al.. (2021). A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge. Antiviral Research. 195. 105179–105179. 22 indexed citations
2.
Colombo, Christopher, Rhonda E Colombo, Ryan C. Maves, et al.. (2021). Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial Cohort. Critical Care Explorations. 3(7). e0474–e0474. 8 indexed citations
3.
Donlin, Maureen J., Eddy C. Hsueh, Theresa Schwartz, et al.. (2020). Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity. Cancer Immunology Research. 9(2). 214–226. 26 indexed citations
4.
5.
Manoff, Susan B., Sarah L. George, Andrew J. Bett, et al.. (2015). Preclinical and clinical development of a dengue recombinant subunit vaccine. Vaccine. 33(50). 7126–7134. 51 indexed citations
6.
George, Sarah L., et al.. (2015). CD8+T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate. The Journal of Infectious Diseases. 212(10). 1618–1628. 52 indexed citations
7.
George, Sarah L., Tina Dube, Karen L. Boroughs, et al.. (2015). Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial. The Journal of Infectious Diseases. 212(7). 1032–1041. 70 indexed citations
8.
Thomas, Benjamin S., Thomas C. Bailey, Julu Bhatnagar, et al.. (2014). Mycobacterium ulceransInfection Imported from Australia to Missouri, USA, 2012. Emerging infectious diseases. 20(11). 1876–1879. 7 indexed citations
9.
10.
Sahly, Hana M. El, Charles E. Davis, Karen L. Kotloff, et al.. (2012). Higher Antigen Content Improves the Immune Response to 2009 H1N1 Influenza Vaccine in HIV-Infected Adults: A Randomized Clinical Trial. The Journal of Infectious Diseases. 205(5). 703–712. 25 indexed citations
11.
Ramadass, Balamurugan, et al.. (2008). Real‐time polymerase chain reaction quantification of specific butyrate‐producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. Journal of Gastroenterology and Hepatology. 23(8pt1). 1298–1303. 237 indexed citations
12.
George, Sarah L., et al.. (2005). What you need to know about GB virus C. Current Gastroenterology Reports. 7(1). 54–62. 8 indexed citations
13.
Xiang, Jinhua, Sarah L. George, Sabina Wünschmann, et al.. (2004). Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MlP-lα, MIP-1β, and SDF-1. The Lancet. 363(9426). 2040–2046. 142 indexed citations
14.
George, Sarah L., Jinhua Xiang, & Jack T. Stapleton. (2003). Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology. 316(2). 191–201. 37 indexed citations
15.
George, Sarah L., Sabina Wünschmann, James McCoy, Jinhua Xiang, & Jack T. Stapleton. (2002). Interactions between GB virus type C and HIV. Current Infectious Disease Reports. 4(6). 550–558. 21 indexed citations
16.
George, Sarah L., et al.. (1999). Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases. The American Journal of Medicine. 107(6). 624–626. 52 indexed citations
17.
George, Sarah L. & Larry S. Schlesinger. (1999). Mycobacterium neoaurum‐An Unusual Cause of Infection of Vascular Catheters: Case Report and Revie. Clinical Infectious Diseases. 28(3). 682–683. 13 indexed citations
18.
George, Sarah L., et al.. (1998). Neutrophils from AIDS Patients Treated with Granulocyte Colony‐Stimulating Factor Demonstrate Enhanced Killing ofMycobacterium avium. The Journal of Infectious Diseases. 178(5). 1530–1533. 13 indexed citations
19.
Coffey, Michael, Susan M. Phare, Sarah L. George, Marc Peters‐Golden, & Powel Kazanjian. (1998). Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.. Journal of Clinical Investigation. 102(4). 663–670. 67 indexed citations
20.
George, Sarah L., et al.. (1997). Advances in the Treatment and Prophylaxis of Pneumocystis carinii Pneumonia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(5). 900–916. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed Tarek M. Shata Breakdown of academic impact, for papers by Matthias Stoll Breakdown of academic impact, for papers by J Giron Breakdown of academic impact, for papers by Manfred Dietrich Breakdown of academic impact, for papers by Caterina Uberti‐Foppa Breakdown of academic impact, for papers by Élisabeth Dussaix Breakdown of academic impact, for papers by Pompeyo Viciana Breakdown of academic impact, for papers by Daniel P. Webster Breakdown of academic impact, for papers by George F. Grady Breakdown of academic impact, for papers by William P. Bradley
Rankless by CCL
2026